Tag: License Agreement

August 20, 2018

RedHill BioPharma Receives New Patent

RedHill Biopharma received a notice of allowance from the US Patent and Trademark Office on Monday for a new formulation...
August 19, 2018

5 Top Weekly NASDAQ Biotech Stocks: Idera Rises to the Top

Idera Pharmaceuticals, Eiger Biopharma, Aevi Genomic Medicine, Evofem Biosciences and Biospecifics Tech were last week's top gainers on the NASDAQ...
August 17, 2018
August 12, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot

Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
August 7, 2018

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China

Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin)...
July 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 13, 2018

Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories

Arcus Biosciences (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that Taiho Pharmaceutical exercised its...
July 9, 2018

5 Top NASDAQ Biotech Stocks Year-to-Date

The biotech industry is a unique intersection of companies. Here's a look at the top-gaining biotech companies on the NASDAQ...
July 3, 2018

4 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...